P

Inventor

WALLACE DAVID MARK

US95 patents
⚠️ This page may combine multiple inventors who share the name “WALLACE DAVID MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAMUMED LLC

44 patents
US9199991B2Dec 1, 2015

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

SAMUMED LLC70 citations99
US9090613B2Jul 28, 2015

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC84 citations99
US9067939B2Jun 30, 2015

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

SAMUMED LLC75 citations99
US8987298B2Mar 24, 2015

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC77 citations99
US8901150B2Dec 2, 2014

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

SAMUMED LLC77 citations99
US8846714B2Sep 30, 2014

1H-pyrazolo[3,4-β]pyridines and therapeutic uses thereof

SAMUMED LLC82 citations99
US8703794B2Apr 22, 2014

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC81 citations99
US8673936B2Mar 18, 2014

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC85 citations99
US8664241B2Mar 4, 2014

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC83 citations99
US8618128B1Dec 31, 2013

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

SAMUMED LLC84 citations99
US8604052B2Dec 10, 2013

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

SAMUMED LLC92 citations99
US9855272B2Jan 2, 2018

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

SAMUMED LLC44 citations98
US9844536B2Dec 19, 2017

3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

SAMUMED LLC49 citations98
US9828372B2Nov 28, 2017

2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof

SAMUMED LLC49 citations98
US9815854B2Nov 14, 2017

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

SAMUMED LLC49 citations98
US9763951B2Sep 19, 2017

3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

SAMUMED LLC49 citations98
US9763927B2Sep 19, 2017

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC49 citations98
US9586977B2Mar 7, 2017

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

SAMUMED LLC49 citations98
US9381192B2Jul 5, 2016

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC49 citations98
US9233104B2Jan 12, 2016

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

SAMUMED LLC67 citations98
US9012472B2Apr 21, 2015

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

SAMUMED LLC73 citations98
US8883822B2Nov 11, 2014

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

SAMUMED LLC76 citations98
US9745271B2Aug 29, 2017

5-substituted indazole-3-carboxamides and preparation and use thereof

SAMUMED LLC58 citations97
US8815897B2Aug 26, 2014

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

SAMUMED LLC82 citations96
US10407425B2Sep 10, 2019

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC15 citations94
US9889140B2Feb 13, 2018

3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

SAMUMED LLC23 citations94
US9540398B2Jan 10, 2017

3-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

SAMUMED LLC33 citations94
US10131677B2Nov 20, 2018

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

SAMUMED LLC15 citations93
US9303010B2Apr 5, 2016

β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators

SAMUMED LLC12 citations92
US8921413B2Dec 30, 2014

β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators

SAMUMED LLC14 citations92
US8629176B1Jan 14, 2014

β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators

SAMUMED LLC17 citations92
US10947228B2Mar 16, 2021

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

SAMUMED LLC9 citations86
US10314832B2Jun 11, 2019

β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators

SAMUMED LLC4 citations84
US9994563B2Jun 12, 2018

Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof

SAMUMED LLC7 citations84
US9884053B2Feb 6, 2018

β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activators

SAMUMED LLC7 citations84
US9533976B2Jan 3, 2017

γ-diketones as WNT/β-catenin signaling pathway activators

SAMUMED LLC9 citations84
US9493437B2Nov 15, 2016

β- and γ-diketones and γ-hydroxyketones as Wnt/ β-catenin signaling pathway activators

SAMUMED LLC8 citations84
US9475807B2Oct 25, 2016

2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof

SAMUMED LLC5 citations84
US10899757B2Jan 26, 2021

2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof

SAMUMED LLC8 citations83
US11034682B2Jun 15, 2021

Gamma-diketones as wnt/β-catenin signaling pathway activators

SAMUMED LLC1 citations73
US10526347B2Jan 7, 2020

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

SAMUMED LLC2 citations73
US10457672B2Oct 29, 2019

γ-diketones as Wnt/β-catenin signaling pathway activators

SAMUMED LLC3 citations73
US10342788B2Jul 9, 2019

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

SAMUMED LLC2 citations73
US10071086B2Sep 11, 2018

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

SAMUMED LLC2 citations73

HOOD JOHN

3 patents

BIOSPLICE THERAPEUTICS INC

2 patents

KC SUNIL KUMAR

1 patent

Showing the top 50 of 95 patents by PatentIndex Score.